Literature DB >> 8950810

Destroying retroviruses from within.

J D Boeke1, B Hahn.   

Abstract

One strategy for neutralizing retroviral infectivity is to induce the incorporation of lethal fusion proteins, such as capsid protein-nuclease fusions, into the virion during the normal viral assembly process. Genes encoding such antiviral fusion proteins must be nontoxic to the host, lethal to the virus, and must be efficiently delivered to, and expressed in, appropriate target cells.

Mesh:

Substances:

Year:  1996        PMID: 8950810     DOI: 10.1016/0966-842x(96)10065-2

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  4 in total

1.  Therapeutic effect of a Gag-nuclease fusion protein against retroviral infection in vivo.

Authors:  G Schumann; M Hermankova; K Cannon; J L Mankowski; J D Boeke
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Evaluation of a system to screen for stimulators of non-specific DNA nicking by HIV-1 integrase: application to a library of 50,000 compounds.

Authors:  Malgorzata Sudol; Jennifer L Fritz; Melissa Tran; Gavin P Robertson; Julie B Ealy; Michael Katzman
Journal:  Antivir Chem Chemother       Date:  2011-10-07

3.  Virion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins.

Authors:  G P Kobinger; A Borsetti; Z Nie; J Mercier; N Daniel; H G Göttlinger; A Cohen
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

4.  Production of uninfectious human immunodeficiency virus type 1 containing viral protein R fused to a single-chain antibody against viral integrase.

Authors:  N Okui; N Kobayashi; Y Kitamura
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.